Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial Optional

The summary for the Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial Optional grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Food and Drug Administration, which is the U.S. government agency offering this grant.
Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial Optional: The purpose of this NOFO is to encourage new approaches to support therapeutic development in ultra-rare pediatric and adult cancers, including molecularly-defined subsets of more common cancers.
Federal Grant Title: Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial Optional
Federal Agency Name: Food and Drug Administration (HHS-FDA)
Grant Categories: Agriculture, Consumer Protection, Food and Nutrition
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-FD-24-038
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.103
CFDA Descriptions: Information not provided
Current Application Deadline: April 5th, 2024
Original Application Deadline: April 5th, 2024
Posted Date: January 31st, 2024
Creation Date: January 31st, 2024
Archive Date: May 5th, 2024
Total Program Funding: $500,000
Maximum Federal Grant Award: $500,000
Minimum Federal Grant Award:
Expected Number of Awards: 1
Cost Sharing or Matching: No
Last Updated: January 31st, 2024
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Foreign Organizations Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement are allowed.
Grant Announcement Contact
Zahara Graves
Grantor
Phone 240-402-0151
Work
Similar Government Grants
Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical T...
Single Source Cooperative Agreement to Support HPAI H5N1 Research at Cornell University (U...
Animal and Veterinary Innovation Centers (U18)
Cooperative Agreement to Support the Illinois Institute of Technology's Institute for Food...
Minor Use Minor Species Development of Drugs (R01)
Support for Small Scientific Conference Grant Program
Cooperative Agreement to Support the World Health Organization (WHO) International Program...
Clinical Studies of Safety and Effectiveness of Orphan Products
More Grants from the Food and Drug Administration
Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical T...
Single Source Cooperative Agreement to Support HPAI H5N1 Research at Cornell University (U...
Animal and Veterinary Innovation Centers (U18)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com